Global Gene-based Therapy Medicinal Market Research Report 2024(Status and Outlook)
Report Overview:
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The Global Gene-based Therapy Medicinal Market Size was estimated at USD 2269.80 million in 2023 and is projected to reach USD 9082.63 million by 2029, exhibiting a CAGR of 26.00% during the forecast period.
This report provides a deep insight into the global Gene-based Therapy Medicinal market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene-based Therapy Medicinal Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene-based Therapy Medicinal market in any manner.
Global Gene-based Therapy Medicinal Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral Gene Delivery System
Non-viral Gene Delivery System
Market Segmentation (by Application)
Neurological Diseases
Cancer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gene-based Therapy Medicinal Market
- Overview of the regional outlook of the Gene-based Therapy Medicinal Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene-based Therapy Medicinal Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Gene-based Therapy Medicinal
- 1.2 Key Market Segments
- 1.2.1 Gene-based Therapy Medicinal Segment by Type
- 1.2.2 Gene-based Therapy Medicinal Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Gene-based Therapy Medicinal Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Gene-based Therapy Medicinal Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Gene-based Therapy Medicinal Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Gene-based Therapy Medicinal Market Competitive Landscape
- 3.1 Global Gene-based Therapy Medicinal Sales by Manufacturers (2019-2024)
- 3.2 Global Gene-based Therapy Medicinal Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Gene-based Therapy Medicinal Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Gene-based Therapy Medicinal Sales Sites, Area Served, Product Type
- 3.6 Gene-based Therapy Medicinal Market Competitive Situation and Trends
- 3.6.1 Gene-based Therapy Medicinal Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Gene-based Therapy Medicinal Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Gene-based Therapy Medicinal Industry Chain Analysis
- 4.1 Gene-based Therapy Medicinal Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Gene-based Therapy Medicinal Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Gene-based Therapy Medicinal Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Gene-based Therapy Medicinal Sales Market Share by Type (2019-2024)
- 6.3 Global Gene-based Therapy Medicinal Market Size Market Share by Type (2019-2024)
- 6.4 Global Gene-based Therapy Medicinal Price by Type (2019-2024)
- 7 Gene-based Therapy Medicinal Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Gene-based Therapy Medicinal Market Sales by Application (2019-2024)
- 7.3 Global Gene-based Therapy Medicinal Market Size (M USD) by Application (2019-2024)
- 7.4 Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2019-2024)
- 8 Gene-based Therapy Medicinal Market Segmentation by Region
- 8.1 Global Gene-based Therapy Medicinal Sales by Region
- 8.1.1 Global Gene-based Therapy Medicinal Sales by Region
- 8.1.2 Global Gene-based Therapy Medicinal Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Gene-based Therapy Medicinal Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Gene-based Therapy Medicinal Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Gene-based Therapy Medicinal Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Gene-based Therapy Medicinal Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Gene-based Therapy Medicinal Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Biogen
- 9.1.1 Biogen Gene-based Therapy Medicinal Basic Information
- 9.1.2 Biogen Gene-based Therapy Medicinal Product Overview
- 9.1.3 Biogen Gene-based Therapy Medicinal Product Market Performance
- 9.1.4 Biogen Business Overview
- 9.1.5 Biogen Gene-based Therapy Medicinal SWOT Analysis
- 9.1.6 Biogen Recent Developments
- 9.2 Novartis
- 9.2.1 Novartis Gene-based Therapy Medicinal Basic Information
- 9.2.2 Novartis Gene-based Therapy Medicinal Product Overview
- 9.2.3 Novartis Gene-based Therapy Medicinal Product Market Performance
- 9.2.4 Novartis Business Overview
- 9.2.5 Novartis Gene-based Therapy Medicinal SWOT Analysis
- 9.2.6 Novartis Recent Developments
- 9.3 Gilead Sciences
- 9.3.1 Gilead Sciences Gene-based Therapy Medicinal Basic Information
- 9.3.2 Gilead Sciences Gene-based Therapy Medicinal Product Overview
- 9.3.3 Gilead Sciences Gene-based Therapy Medicinal Product Market Performance
- 9.3.4 Gilead Sciences Gene-based Therapy Medicinal SWOT Analysis
- 9.3.5 Gilead Sciences Business Overview
- 9.3.6 Gilead Sciences Recent Developments
- 9.4 Sarepta Therapeutics
- 9.4.1 Sarepta Therapeutics Gene-based Therapy Medicinal Basic Information
- 9.4.2 Sarepta Therapeutics Gene-based Therapy Medicinal Product Overview
- 9.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Product Market Performance
- 9.4.4 Sarepta Therapeutics Business Overview
- 9.4.5 Sarepta Therapeutics Recent Developments
- 9.5 Alnylam Pharmaceuticals
- 9.5.1 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Basic Information
- 9.5.2 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Overview
- 9.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Market Performance
- 9.5.4 Alnylam Pharmaceuticals Business Overview
- 9.5.5 Alnylam Pharmaceuticals Recent Developments
- 9.6 Amgen
- 9.6.1 Amgen Gene-based Therapy Medicinal Basic Information
- 9.6.2 Amgen Gene-based Therapy Medicinal Product Overview
- 9.6.3 Amgen Gene-based Therapy Medicinal Product Market Performance
- 9.6.4 Amgen Business Overview
- 9.6.5 Amgen Recent Developments
- 9.7 Spark Therapeutics
- 9.7.1 Spark Therapeutics Gene-based Therapy Medicinal Basic Information
- 9.7.2 Spark Therapeutics Gene-based Therapy Medicinal Product Overview
- 9.7.3 Spark Therapeutics Gene-based Therapy Medicinal Product Market Performance
- 9.7.4 Spark Therapeutics Business Overview
- 9.7.5 Spark Therapeutics Recent Developments
- 9.8 Akcea Therapeutics
- 9.8.1 Akcea Therapeutics Gene-based Therapy Medicinal Basic Information
- 9.8.2 Akcea Therapeutics Gene-based Therapy Medicinal Product Overview
- 9.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Product Market Performance
- 9.8.4 Akcea Therapeutics Business Overview
- 9.8.5 Akcea Therapeutics Recent Developments
- 9.9 Sunway Biotech
- 9.9.1 Sunway Biotech Gene-based Therapy Medicinal Basic Information
- 9.9.2 Sunway Biotech Gene-based Therapy Medicinal Product Overview
- 9.9.3 Sunway Biotech Gene-based Therapy Medicinal Product Market Performance
- 9.9.4 Sunway Biotech Business Overview
- 9.9.5 Sunway Biotech Recent Developments
- 9.10 SIBIONO
- 9.10.1 SIBIONO Gene-based Therapy Medicinal Basic Information
- 9.10.2 SIBIONO Gene-based Therapy Medicinal Product Overview
- 9.10.3 SIBIONO Gene-based Therapy Medicinal Product Market Performance
- 9.10.4 SIBIONO Business Overview
- 9.10.5 SIBIONO Recent Developments
- 9.11 AnGes
- 9.11.1 AnGes Gene-based Therapy Medicinal Basic Information
- 9.11.2 AnGes Gene-based Therapy Medicinal Product Overview
- 9.11.3 AnGes Gene-based Therapy Medicinal Product Market Performance
- 9.11.4 AnGes Business Overview
- 9.11.5 AnGes Recent Developments
- 9.12 Orchard Therapeutics
- 9.12.1 Orchard Therapeutics Gene-based Therapy Medicinal Basic Information
- 9.12.2 Orchard Therapeutics Gene-based Therapy Medicinal Product Overview
- 9.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Product Market Performance
- 9.12.4 Orchard Therapeutics Business Overview
- 9.12.5 Orchard Therapeutics Recent Developments
- 9.13 Human Stem Cells Institute
- 9.13.1 Human Stem Cells Institute Gene-based Therapy Medicinal Basic Information
- 9.13.2 Human Stem Cells Institute Gene-based Therapy Medicinal Product Overview
- 9.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Product Market Performance
- 9.13.4 Human Stem Cells Institute Business Overview
- 9.13.5 Human Stem Cells Institute Recent Developments
- 10 Gene-based Therapy Medicinal Market Forecast by Region
- 10.1 Global Gene-based Therapy Medicinal Market Size Forecast
- 10.2 Global Gene-based Therapy Medicinal Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Gene-based Therapy Medicinal Market Size Forecast by Country
- 10.2.3 Asia Pacific Gene-based Therapy Medicinal Market Size Forecast by Region
- 10.2.4 South America Gene-based Therapy Medicinal Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Gene-based Therapy Medicinal by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Gene-based Therapy Medicinal Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Gene-based Therapy Medicinal by Type (2025-2030)
- 11.1.2 Global Gene-based Therapy Medicinal Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Gene-based Therapy Medicinal by Type (2025-2030)
- 11.2 Global Gene-based Therapy Medicinal Market Forecast by Application (2025-2030)
- 11.2.1 Global Gene-based Therapy Medicinal Sales (Kilotons) Forecast by Application
- 11.2.2 Global Gene-based Therapy Medicinal Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook